In an effort to accelerate the adoption of Watson cognitive computing in health care, IBM has invested in EHR provider, Modernizing Medicine. The investment caps $20 million in Series D funding secured by Modernizing Medicine, raising its overall funding total to $49 million.
The funding from IBM and other investors will help Modernizing Medicine, creator of Electronic Medical Assistant (EMA), accelerate market expansion in eight medical specialties, as well as enhance and expand its suite of solutions—including further development of schEMA, the company’s mobile app accessed through EMA that leverages the cognitive computing power of Watson to give physicians rapid clinical decision support at the point of care.
“Modernizing Medicine is a great example of the breakthrough innovation we have seen from our partners who are building a new class of cognitive computing solutions powered by Watson,” said Stephen Gold, vice president of IBM Watson. “IBM’s investment will help speed the introduction of their schEMA app and demonstrates how Watson can be used by medical professionals to improve how they practice evidence-based medicine.”
